Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO · BSE: 524518 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹59.90
Market cap: ₹129.2 Cr
Revenue (annual): ₹23.73 Cr
Net profit (annual): ₹-16.93 Cr
P/E (TTM): -9.2×Sector 47.4×
Promoter holding: 72.74%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Price Movement Clarification 2 Other Announcement 2 Board Meeting Date 2 Merger & Restructuring 1 Legal & Regulatory 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 May 2026 11:05 IST BSE

Other Announcement

Krebs Biochemicals & Industries Other Announcement

Krebs Biochemicals submitted its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details governance compliance and historical penalties for board composition.

Read the filing ↗

7 Apr 2026 10:46 IST BSE

Other Announcement

Krebs Biochemicals & Industries Other Announcement

Krebs Biochemicals & Industries Limited submitted the RTA certificate under Regulation 74(5) of SEBI DP Regulations for the quarter ended March 31, 2026. The filing confirms compliance regarding the dematerialization and rematerialization of securities during the period.

Read the filing ↗